Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003063425 | SCV003456491 | uncertain significance | not provided | 2022-07-29 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs766425306, gnomAD 0.03%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with SLC2A9-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 181 of the SLC2A9 protein (p.Ala181Thr). |
Chinese Inherited Urolithiasis Consortium, |
RCV004763527 | SCV005368639 | likely pathogenic | Hypouricemia, renal, 2 | 2024-08-26 | no assertion criteria provided | clinical testing | Variant_type:missense/MutationTaster:Polymorphism/CADD:Tolerable/phyloP:Nonconserved/phastCons:Nonconserved/gnomAD_exome_EastAsian:0/ExAC_EastAsian:0.0001/dbSNP:rs766425306 |